Are you Dr. Xu?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
5323 Harry Hines Blvd
# The
Dallas, TX 75390Phone+1 214-648-3111
Summary
- Dr. Xiang Xu, MD is a board certified pathologist in Dallas, Texas. He is currently licensed to practice medicine in Massachusetts and Pennsylvania. He is affiliated with Beth Israel Deaconess Hospital-Needham and Beth Israel Deaconess Hospital-Needham.
Education & Training
China Medical University (Taiwan) Class of 2001
Certifications & Licensure
MA State Medical License 2021 - 2025
PA State Medical License 2021 - 2022- American Board of Pathology Pathology - Anatomic/Pathology - Clinical
- American Board of Pathology Hematopathology
Publications & Presentations
PubMed
- 29 citationsIdentification of a new epitope in uPAR as a target for the cancer therapeutic monoclonal antibody ATN-658, a structural homolog of the uPAR binding integrin CD11b (αM).Xiang Xu, Yuan Cai, Ying Wei, Fernando Donate, Jose Juarez
Plos One. 2014-01-21 - 41 citationsStructural and Atropisomeric Factors Governing the Selectivity of Pyrimido-benzodiazipinones as Inhibitors of Kinases and BromodomainsJinhua Wang, Tatiana Erazo, Fleur M. Ferguson, Dennis L. Buckley, Néstor Gómez
ACS Chemical Biology. 2018-09-21 - 7 citationsVariable Expression of S100 Protein in Sinonasal Malignant Mucosal Melanoma: A Potential Diagnostic PitfallXiang Xu, Doreen N. Palsgrove, Elizabeth M. Kurian, Shirley Yan, Bahram R. Oliai
Head and Neck Pathology. 2020-04-01
Press Mentions
- Trump’s ‘Chinese Virus’ Tweet Linked to Rise of Anti-Asian Hashtags on TwitterMarch 22nd, 2021
Adverse Effects of Esketamine for the Treatment of Major Depression Disorder: Findings from Randomized Controlled TrialsJanuary 7th, 2021- HDAC2 Inhibits EMT-Mediated Cancer Metastasis by Downregulating the Long Noncoding RNA H19 in Colorectal CancerDecember 2nd, 2020
- Join now to see all
